Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 1/20 | 0.46 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.46 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.46 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15189352 | 0.85 | PRMT1 (0.50) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL15444588 | 0.85 | CYP2C9 (0.37) | SIGMAR1CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL13745027 | 0.83 | PRMT3 (0.42) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL8347657 | 0.83 | PRMT1 (0.48) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL8503680 | 0.83 | PRMT1 (0.70) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL25556027 | 0.83 | CYP2C9 (0.36) | SIGMAR1CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL4275940 | 0.82 | — | — | |
| SCHEMBL21516568 | 0.82 | PRMT3 (0.42) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL25920449 | 0.82 | PRMT3 (0.42) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL1697723 | 0.82 | PRMT1 (0.65) | PRMT3CARM1PRMT6PRMT1PRMT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018087635-A1 | IMMUNOGENIC POLYSACCHARIDE PROTEIN CONJUGATED COMPRISING A POLYSACCHARIDE DERIVED FROM B STREPTOCOCCUS GBS | PFIZER INC. (US) | 2018-05-17 | — | — | WO | disclosed |
| US-8574384-B1 | Tags for the sorting of plastics | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-11-05 | — | — | US | disclosed |
| US-20120003271-A1 | POLYMER BLENDS | The University Court of th University of Edinburgh (GB) | 2012-01-05 | — | — | US | disclosed |
| US-20110226621-A1 | TARGET RECOGNITION MOLECULE AND A METHOD FOR IMMOBILIZING THE SAME | SHARP KABUSHIKI KAISHA (JP) | 2011-09-22 | — | — | US | disclosed |
| US-20110017599-A1 | TARGET RECOGNITION MOLECULE AND A METHOD FOR IMMOBILIZING THE SAME | SHARP KABUSHIKI KAISHA (JP) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120003271-A1 | POLYMER BLENDS | LDHB, LRBA, LDHA | PRMT3 649/4885CARM1 51/4885PRMT6 705/4885 |
| US-20110017599-A1 | TARGET RECOGNITION MOLECULE AND A METHOD FOR IMMOBILIZING THE SAME | STUB1, EPCAM, CD2BP2 | PRMT3 669/4885CARM1 1948/4885PRMT6 378/4885 |
| US-20110226621-A1 | TARGET RECOGNITION MOLECULE AND A METHOD FOR IMMOBILIZING THE SAME | CD74, EPCAM, CD14 | PRMT3 553/4885CARM1 1556/4885PRMT6 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.